Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia

Background: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflam...

Full description

Bibliographic Details
Main Authors: Jacob B. Ruden, Kevin L. Quick, Ernesto R. Gonzales, Aarti R. Shah, T. S. Park, Nan Kennedy, Laura L. Dugan, Jeffrey M. Gidday
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00447/full
id doaj-10df08ffead34f4eb3cfb11b99717d32
record_format Article
spelling doaj-10df08ffead34f4eb3cfb11b99717d322020-11-25T02:27:42ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-05-011010.3389/fneur.2019.00447450892Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal AsphyxiaJacob B. Ruden0Kevin L. Quick1Ernesto R. Gonzales2Aarti R. Shah3Aarti R. Shah4T. S. Park5Nan Kennedy6Laura L. Dugan7Laura L. Dugan8Jeffrey M. Gidday9Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United StatesPerkinElmer, Waltham, MA, United StatesHope Center for Neurological Disorders and Department of Neurology, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesHope Center for Neurological Disorders and Department of Neurology, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesKnight Alzheimer's Disease Research Center, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesDepartment of Neurosurgery, St. Louis Children's Hospital, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United StatesVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United StatesDivision of Geriatric Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United StatesDepartments of Ophthalmology, Physiology, and Neuroscience, Louisiana State University School of Medicine, New Orleans, LA, United StatesBackground: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflammatory response and blood-brain barrier (BBB) breakdown. We investigated the effects of removing O2⋅_ by superoxide dismutase (SOD) or C3, the cell-permeable SOD mimetic, in protecting against asphyxia-related leukocyte recruitment. We also tested the hypothesis that xanthine oxidase activity is one source of this radical.Methods: Anesthetized piglets were tracheostomized, ventilated, and equipped with closed cranial windows for the assessment of post-asphyxial rhodamine 6G-labeled leukocyte-endothelial adherence and microvascular permeability to sodium fluorescein in cortical venules. Asphyxia was induced by discontinuing ventilation. SOD and C3 were administered by cortical superfusion. The xanthine oxidase inhibitor oxypurinol was administered intravenously.Results: Leukocyte-venular adherence significantly increased during the initial 2 h of post-asphyxial reperfusion. BBB permeability was also elevated relative to non-asphyxial controls. Inhibition of O2⋅_ production by oxypurinol, or elimination of O2⋅_ by SOD or C3, significantly reduced rhodamine 6G-labeled leukocyte-endothelial adherence and improved BBB integrity, as measured by sodium fluorescein leak from cerebral microvessels.Conclusion: Using three different strategies to either prevent formation or enhance elimination of O2⋅_ during the post-asphyxial period, we saw both reduced leukocyte adherence and preserved BBB function with treatment. These findings suggest that agents which lower O2⋅_ in brain may be attractive new therapeutic interventions for the protection of the neonatal brain following asphyxia.https://www.frontiersin.org/article/10.3389/fneur.2019.00447/fullasphyxiacarboxyfullereneendotheliuminflammationleukocytesoxypurinol
collection DOAJ
language English
format Article
sources DOAJ
author Jacob B. Ruden
Kevin L. Quick
Ernesto R. Gonzales
Aarti R. Shah
Aarti R. Shah
T. S. Park
Nan Kennedy
Laura L. Dugan
Laura L. Dugan
Jeffrey M. Gidday
spellingShingle Jacob B. Ruden
Kevin L. Quick
Ernesto R. Gonzales
Aarti R. Shah
Aarti R. Shah
T. S. Park
Nan Kennedy
Laura L. Dugan
Laura L. Dugan
Jeffrey M. Gidday
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
Frontiers in Neurology
asphyxia
carboxyfullerene
endothelium
inflammation
leukocytes
oxypurinol
author_facet Jacob B. Ruden
Kevin L. Quick
Ernesto R. Gonzales
Aarti R. Shah
Aarti R. Shah
T. S. Park
Nan Kennedy
Laura L. Dugan
Laura L. Dugan
Jeffrey M. Gidday
author_sort Jacob B. Ruden
title Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
title_short Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
title_full Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
title_fullStr Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
title_full_unstemmed Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
title_sort reduction of leukocyte microvascular adherence and preservation of blood-brain barrier function by superoxide-lowering therapies in a piglet model of neonatal asphyxia
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2019-05-01
description Background: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflammatory response and blood-brain barrier (BBB) breakdown. We investigated the effects of removing O2⋅_ by superoxide dismutase (SOD) or C3, the cell-permeable SOD mimetic, in protecting against asphyxia-related leukocyte recruitment. We also tested the hypothesis that xanthine oxidase activity is one source of this radical.Methods: Anesthetized piglets were tracheostomized, ventilated, and equipped with closed cranial windows for the assessment of post-asphyxial rhodamine 6G-labeled leukocyte-endothelial adherence and microvascular permeability to sodium fluorescein in cortical venules. Asphyxia was induced by discontinuing ventilation. SOD and C3 were administered by cortical superfusion. The xanthine oxidase inhibitor oxypurinol was administered intravenously.Results: Leukocyte-venular adherence significantly increased during the initial 2 h of post-asphyxial reperfusion. BBB permeability was also elevated relative to non-asphyxial controls. Inhibition of O2⋅_ production by oxypurinol, or elimination of O2⋅_ by SOD or C3, significantly reduced rhodamine 6G-labeled leukocyte-endothelial adherence and improved BBB integrity, as measured by sodium fluorescein leak from cerebral microvessels.Conclusion: Using three different strategies to either prevent formation or enhance elimination of O2⋅_ during the post-asphyxial period, we saw both reduced leukocyte adherence and preserved BBB function with treatment. These findings suggest that agents which lower O2⋅_ in brain may be attractive new therapeutic interventions for the protection of the neonatal brain following asphyxia.
topic asphyxia
carboxyfullerene
endothelium
inflammation
leukocytes
oxypurinol
url https://www.frontiersin.org/article/10.3389/fneur.2019.00447/full
work_keys_str_mv AT jacobbruden reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT kevinlquick reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT ernestorgonzales reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT aartirshah reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT aartirshah reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT tspark reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT nankennedy reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT lauraldugan reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT lauraldugan reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
AT jeffreymgidday reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia
_version_ 1724841271833395200